Moderna is suing fellow vaccine developers Pfizer and its German partner BioNTech, accusing it of infringing on patents related to mRNA technology used in their COVID-19 vaccine, the company announced ...

Moderna MRNA has filed lawsuits against rivals Pfizer PFE and BioNTech BNTX, alleging that their COVID-19 vaccine, Comirnaty infringes on patents related to its mRNA technology platform. The ...

By updating the genetic code inside mRNA vaccines every year, scientists can keep population-level immunity aligned with ...

(Reuters) - CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA technology and that a U.S. court had granted its request ...

Research reveals mRNA COVID-19 vaccines may enhance cancer immunotherapy effectiveness, extending survival for lung and skin ...

Moderna is suing competing vaccine maker, Pfizer, and partner company BioNTech. Moderna alleges that Pfizer infringed on patents for its mRNA vaccine technology. Moderna said it developed the ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird flu ...

Australia's Victoria state on Wednesday unveiled plans to develop an onshore messenger-RNA (mRNA) vaccine manufacturing facility and launched three mass coronavirus immunisation centres to speed up ...

When most of us think of mRNA technology, we probably think of Moderna(NASDAQ: MRNA). The biotech company put messenger RNA on the map when it brought the first coronavirus vaccine candidate into ...

Moderna said it is suing Pfizer and its German partner BioNTech for patent infringement linked to the development of the first Covid-19 vaccines. The US biotech company is alleging that mRNA ...

Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a pivotal Phase 3 clinical trial to evaluate the efficacy, safety, tolerability and immunogenicity of the company ...